A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors

LESSONS LEARNED: Pancreatic neuroendocrine tumors versus carcinoid tumors should be examined separately in clinical trials. Progression-free survival is more clinically relevant as the primary endpoint (rather than response rate) in phase II trials for low-grade neuroendocrine tumors. BACKGROUND. Th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Jin, Ning, Lubner, Sam J., Mulkerin, Daniel L., Rajguru, Saurabh, Carmichael, Lakeesha, Chenv, Herb, Holen, Kyle D., LoConte, Noelle K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2016
Gaiak:
Clinical Trial Results
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4943400/
https://ncbi.nlm.nih.gov/pubmed/27261467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0060
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak